دورية أكاديمية

Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed Death Ligand 1–Expressing NSCLC

التفاصيل البيبلوغرافية
العنوان: Health-Related Quality of Life in KEYNOTE-010: a Phase II/III Study of Pembrolizumab Versus Docetaxel in Patients With Previously Treated Advanced, Programmed Death Ligand 1–Expressing NSCLC
المؤلفون: Barlesi, Fabrice, Garon, Edward B., Kim, Dong-Wan, Felip, Enriqueta, Han, Ji-Youn, Kim, Joo-Hang, Ahn, Myung-Ju, Fidler, Mary Jo, Gubens, Matthew A., de Castro, Gilberto, Jr., Surmont, Veerle, Li, Qiao, Deitz, Anne C., Lubiniecki, Gregory M., Herbst, Roy S.
المصدر: In Journal of Thoracic Oncology May 2019 14(5):793-801
قاعدة البيانات: ScienceDirect
الوصف
تدمد:15560864
DOI:10.1016/j.jtho.2019.01.016